Workflow
Sanmina Reports First Quarter Fiscal 2025 Financial Results
Prnewswire· 2025-01-27 21:01
SAN JOSE, Calif., Jan. 27, 2025 /PRNewswire/ -- Sanmina Corporation ("Sanmina" or the "Company") (NASDAQ: SANM), a leading integrated manufacturing solutions company, today reported financial results for the first quarter ended December 28, 2024 and outlook for its second fiscal quarter ending March 29, 2025. First Quarter Fiscal 2025 Financial Highlights •    Revenue: $2.01 billion •    GAAP operating margin: 4.4% •    GAAP diluted EPS: $1.16 •    Non-GAAP(1) operating margin: 5.6% •    Non-GAAP(1) dilut ...
AGNC Investment Corp. Announces Fourth Quarter 2024 Financial Results
Prnewswire· 2025-01-27 21:01
BETHESDA, Md., Jan. 27, 2025 /PRNewswire/ -- AGNC Investment Corp. ("AGNC" or the "Company") (Nasdaq: AGNC) today announced financial results for the quarter ended December 31, 2024.FOURTH QUARTER 2024 FINANCIAL HIGHLIGHTS $(0.11) comprehensive loss per common share, comprised of: $0.10 net income per common share $(0.20) other comprehensive loss ("OCI") per common share on investments marked-to-market through OCI $0.37 net spread and dollar roll income per common share1 Excludes $0.06 per common share ...
3 Blue-Chip Retail Stocks You Can Trust for Long-Term Gains
ZACKS· 2025-01-27 21:00
Key TakeawaysHigh-risk, high-reward stocks often make headlines, but blue-chip companies are important in any portfolio.Long-term stock gains and consistent growth often follow companies with substantial market capitalization.Walmart, Costco Wholesale and Home Depot are industry giants with a strong history of financial resilience.In the dynamic world of investing, finding the right balance between risk and reward is like walking a tightrope. While the promise of quick profits can be alluring, it is equally ...
Eastman Chemical to Post Q4 Earnings: What's in Store for the Stock?
ZACKS· 2025-01-27 21:00
Key TakeawaysEMN shares surpassed Zacks Consensus Estimate for earnings in each of the last four quarters.EMN stock has gained 9.6% in the past year compared with the wider chemical industry 1.9% decline.The Zacks model predicts an earnings beat for Eastman Chemical for a fifth straight quarter.Eastman Chemical Company (EMN) is scheduled to release fourth-quarter 2024 results after the closing bell on Jan. 30.See the Zacks Earnings Calendar to stay ahead of market-making news.EMN surpassed Zacks Consensus E ...
HZJL Cayman Limited Announces Entering into a Merger Agreement with Rising Dragon Acquisition Corporation
GlobeNewswire News Room· 2025-01-27 21:00
HANGZHOU, CHINA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- HZJL Cayman Limited (“HZJL”), a comprehensive solution provider empowering local businesses with innovative branding, software, and supply chain services, announced the execution of an Agreement and Plan of Merger (the “Merger Agreement”) for a business combination with Rising Dragon Acquisition Corporation (Nasdaq: RDACU, RDAC, RDACR) (“RDAC”), a publicly traded special purpose acquisition company. Upon consummation of the transaction contemplated by the M ...
GM declares quarterly dividend
Prnewswire· 2025-01-27 21:00
DETROIT, Jan. 27, 2025 /PRNewswire/ -- General Motors (NYSE: GM) announced today that its Board of Directors has declared a quarterly cash dividend on the company's outstanding common stock of $0.12 per share, payable March 20, 2025, to holders of the Company's common stock at the close of trading on March 7, 2025.General Motors (NYSE:GM) is driving the future of transportation, leveraging advanced technology to build safer, smarter, and lower emission cars, trucks, and SUVs. GM's Buick, Cadillac, Chevrolet ...
ZK International Group Announces 405% Gross Profit Increase for the Fiscal Year 2024
Prnewswire· 2025-01-27 21:00
WENZHOU, China, Jan. 27, 2025 /PRNewswire/ -- ZK International Group Co., Ltd. (ZKIN) ("ZK International" or the "Company"), a leader in high-performance stainless steel and carbon steel pipe solutions, is pleased to announce a significant turnaround in its financial performance for the fiscal year ended September 30, 2024, achieving 405% increase in gross profit while also decreasing its net loss significantly by 95.44%.Financial Highlights for the Fiscal Year 2024 For the Fiscal Year Ended September 3 ...
Heritage Bank Expands Into the Spokane, Washington, Market
Prnewswire· 2025-01-27 21:00
OLYMPIA, Wash., Jan. 27, 2025 /PRNewswire/ -- Heritage Bank ("Heritage" or "bank"), a wholly-owned subsidiary of Heritage Financial Corporation (Nasdaq: HFWA), is pleased to announce its expansion into Spokane, Wash., with the addition of James Krejci, senior vice president, commercial team leader; Timothy Engh, senior vice president, commercial banking officer; and Sean O'Regan, vice president, commercial banking officer. Subject to the completion of certain conditions, including receipt of the necessary r ...
Lake Shore Bancorp, Inc. Declares Fourth Quarter 2024 Dividend
GlobeNewswire News Room· 2025-01-27 21:00
DUNKIRK, N.Y., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Lake Shore Bancorp, Inc. (the “Company”) (NASDAQ: LSBK), the holding company for Lake Shore Savings Bank (the “Bank”), announced today that the Board of Directors declared a cash dividend of $0.18 per share on its outstanding common stock on January 27, 2025. The dividend is expected to be paid on February 14, 2025 to stockholders of record as of February 10, 2025. The Company received the written approval from the Federal Reserve Bank of Philadelphia (the “R ...
Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA)
GlobeNewswire News Room· 2025-01-27 21:00
WALTHAM, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for the every-other-month treatment of adult patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) with an intact fovea and when central vision is threatened by GA lesion growth. SYFOVRE is the first and only approved treatment for GA in Australia. "The approval of SYFOVRE marks ...